Cathay International's Lansen to appoint Chen Li as CEO
Source - SMW
Cathay International's majority owned subsidiary Lansen Pharmaceutical Holdings announced Friday that Mr. Chen Li will be appointed as the Executive Managing Director of Lansen, a member of the Executive Committee and the Chief Executive Officer of the Lansen group with effect from 1 March 2018.
Mr. Chen Li, age 56, has over 25 years of experience in the pharmaceutical industry. Prior to joining the Lansen group, Mr. Chen has been General Manager in Alfa Wassermann China since July 2014. Mr. Chen worked for a number of internationally renowned pharmaceutical companies in the past.
At 9:17am: (LON:CTI) Cathay International Holdings Ltd share price was 0p at 7.13p